Bacteria News and Research

RSS

TaiGen Biotechnology's nemonoxacin Phase II study in DFI meets primary endpoints

TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability.

12 Mar 2010

PolyMedix presents data from PMX-30063 defensin-mimetic antibiotic compound Phase 1B study at 8th TSIS

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has presented for the first time to the medical community data from its Phase 1B clinical study with its defensin-mimetic antibiotic compound, PMX-30063.

12 Mar 2010

Bayer HealthCare Pharmaceuticals' ciprofloxacin DPI granted FDA orphan drug designation for CF treatment

Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients. A similar designation has already been granted by the European Medicines Agency.

12 Mar 2010

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

Accelr8 Technology Corporation today announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis.

10 Mar 2010

USA/Ireland Functional Foods conference to focus on science of gut function and response to diet

Understanding the science of how the human gut functions and the role that diet plays in human health will be explored at a major International Functional Foods conference in Cork, this week. Foods have an enormous role to play in keeping people healthy and many foods have properties that can enhance the health of those that consume them.

10 Mar 2010

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae-rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels.

9 Mar 2010

Study shows NK cells use bungee-like nanotube to destroy dangerous cells

Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published today in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them.

9 Mar 2010

Scientists identify the role of vitamin D in activation of T cells

Scientists at the University of Copenhagen have discovered that Vitamin D is crucial to activating our immune defenses and that without sufficient intake of the vitamin, the killer cells of the immune system - T cells - will not be able to react to and fight off serious infections in the body.

8 Mar 2010

Threat of food supply contamination: National sanitary standards on pallet industry needed

The need to set national sanitary standards on the pallet industry to curb the threat of contamination to the U.S. food supply was drawn into sharp relief by a just-issued report by the Produce Safety Project showing acute foodborne illness costs the nation $152 billion annually in healthcare, workplace and other economic losses.

6 Mar 2010

MicroPhage seeks FDA clearance for MRSA/MSSA Blood Culture Test, submits clinical study data

MicroPhage announced that it has submitted human data from a pivotal clinical study of its ‘Microphage MRSA/MSSA Blood Culture Test’ to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage’s instrument-free, rapid tests is based on the Company’s patented Bacteriophage Amplification platform technology. MicroPhage further announced that it has already begun OUS commercial shipments of the test.

5 Mar 2010

TLR's role in HIV-1 reactivation induced by periodontal pathogens

Today, during the 39th Annual Meeting of the American Association for Dental Research, convening at the Walter E. Washington Convention Center in Washington, DC, lead researcher O.A. Gonzalez (University of Kentucky, Lexington) will present a poster of a study titled "TLR2 and TLR9 Activation by Periodontal Pathogens induce HIV-1 Reactivation."

5 Mar 2010

Gene involved in susceptibility and resistance to TB identified

University of Washington researchers have identified a gene involved in susceptibility and resistance to tuberculosis. This same gene, they have found, has a role in the severity of leprosy, which is caused by a related pathogen. The researchers also have learned why this gene is important for susceptibility.

5 Mar 2010

Scientists devise worldwide alert system to monitor contaminated food products

Countries producing food containing harmful bacteria and toxins could be named and shamed more quickly using a worldwide alert system devised by a team of scientists from Kingston University in South West London. The team, led by Professor Declan Naughton, says the easy to use computer tool can be used to monitor contaminated products; helping to prevent them reaching shop shelves and ensuring that food is safe to eat.

5 Mar 2010

Proper diagnosis, treatment and good skin care help control acne and rosacea

Acne and rosacea are two seemingly different skin conditions that have one important thing in common: both are chronic and extremely common skin conditions. However, dermatologists recommend that with proper diagnosis, treatment and a healthy dose of good, old-fashioned skin care, acne and rosacea can be less of a nuisance for patients.

5 Mar 2010

Study: Genetic variant of LTA4H offers protection against TB and leprosy

A study into why some people are more resistant than others to diseases such as tuberculosis (TB) and leprosy has identified a new genetic variant which affects susceptibility to these diseases. The findings, published today in the journal Cell, may have implications for future treatments for the two conditions.

5 Mar 2010

Scientists, researchers and healthcare professionals to convene in Atlanta to set agenda for HAI prevention

Three thousand scientists, researchers and healthcare professionals from throughout the world specializing in epidemiology and infectious diseases will convene March 18-22 in Atlanta with the goal of setting the agenda for healthcare-associated infection (HAI) prevention for the next decade.

4 Mar 2010

Scientists explore household bacteria to produce top-quality cheese

The Norwegian dairy company TINE is now planning an in-depth study that will find out whether household bacteria can be used for their own sake.

4 Mar 2010

Nanoparticle growing in popularity as bactericidal agent shown to be toxic to fish: Study

A nanoparticle growing in popularity as a bactericidal agent has been shown to be toxic to fish, according to a Purdue University study.

4 Mar 2010

Study: Bacteria, fungi and other microbes live in our gut are essential contributors to good health

The thousands of bacteria, fungi and other microbes that live in our gut are essential contributors to our good health. They break down toxins, manufacture some vitamins and essential amino acids, and form a barrier against invaders. A study published today in Nature shows that, at 3.3 million, microbial genes in our gut outnumber previous estimates for the whole of the human body.

4 Mar 2010

Study: 73% of disadvantaged kids in Los Angeles County have untreated caries

A huge percentage of underprivileged kids in Los Angeles County have infectious dental disease that's gone unchecked, according to a study led by the Herman Ostrow School of Dentistry of the University of Southern California.

4 Mar 2010

Bacteria News and Research

TaiGen Biotechnology's nemonoxacin Phase II study in DFI meets primary endpoints

PolyMedix presents data from PMX-30063 defensin-mimetic antibiotic compound Phase 1B study at 8th TSIS

Bayer HealthCare Pharmaceuticals' ciprofloxacin DPI granted FDA orphan drug designation for CF treatment

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

USA/Ireland Functional Foods conference to focus on science of gut function and response to diet

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Study shows NK cells use bungee-like nanotube to destroy dangerous cells

Scientists identify the role of vitamin D in activation of T cells

Threat of food supply contamination: National sanitary standards on pallet industry needed

MicroPhage seeks FDA clearance for MRSA/MSSA Blood Culture Test, submits clinical study data

TLR's role in HIV-1 reactivation induced by periodontal pathogens

Gene involved in susceptibility and resistance to TB identified

Scientists devise worldwide alert system to monitor contaminated food products

Proper diagnosis, treatment and good skin care help control acne and rosacea

Study: Genetic variant of LTA4H offers protection against TB and leprosy

Scientists, researchers and healthcare professionals to convene in Atlanta to set agenda for HAI prevention

Scientists explore household bacteria to produce top-quality cheese

Nanoparticle growing in popularity as bactericidal agent shown to be toxic to fish: Study

Study: Bacteria, fungi and other microbes live in our gut are essential contributors to good health

Study: 73% of disadvantaged kids in Los Angeles County have untreated caries

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo